Holen Sie sich die Stockscreener-App
16.70
2.38%
0.365
Schlusskurs vom Vortag:
$16.33
Offen:
$16.27
24-Stunden-Volumen:
147.61K
Relative Volume:
0.38
Marktkapitalisierung:
$769.01M
Einnahmen:
$526.52M
Nettoeinkommen (Verlust:
$32.53M
KGV:
24.72
EPS:
0.6755
Netto-Cashflow:
$26.48M
1W Leistung:
-0.24%
1M Leistung:
+5.09%
6M Leistung:
+35.05%
1J Leistung:
+39.09%
1-Tages-Spanne:
$16.07
$16.87
1-Wochen-Bereich:
$16.07
$17.36
52-Wochen-Spanne:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
16.70 | 751.97M | 526.52M | 32.53M | 26.48M | 0.6755 |
SLB
Slb Ltd
|
49.74 | 74.22B | 35.69B | 3.45B | 4.54B | 2.3617 |
BKR
Baker Hughes Company
|
60.62 | 59.88B | 27.73B | 2.62B | 2.54B | 2.605 |
HAL
Halliburton Co
|
37.84 | 31.88B | 22.18B | 1.29B | 1.67B | 1.5088 |
TS
Tenaris S A Adr
|
58.48 | 29.34B | 12.00B | 1.98B | 2.02B | 3.6742 |
FTI
Technipfmc Plc
|
71.50 | 28.41B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
CLB PE Ratio & Valuation, Is CLB Overvalued - Intellectia AI
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Core Laboratories Inc. (CLB) Stock Forecasts - Yahoo! Finance Canada
Core Laboratories : 2025 Annual Report - marketscreener.com
Death Cross: Is Core Laboratories Inc likely to announce a buyback2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Core Laboratories (NYSE: CLB) details 2026 director elections, pay plan and KPMG ratification - Stock Titan
Can Core Laboratories Inc be the next market leaderPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Core Laboratories Hits Day High with Strong 7.25% Intraday Surge - Markets Mojo
Core Laboratories Inc. (CLB) Stock forecasts - Yahoo Finance UK
Precision Trading with Core Laboratories Inc. (CLB) Risk Zones - news.stocktradersdaily.com
Middle East conflict weighs on Core Laboratories' Q1 outlook - MSN
Zacks Research Brokers Boost Earnings Estimates for CLB - Defense World
Core Laboratories (NYSE:CLB) Trading Up 5.5%Here's Why - MarketBeat
Core Laboratories and Gevo Stocks Trade Up, What You Need To Know - TradingView
Aug Setups: Is Core Laboratories Inc likely to announce a buyback2026 Trading Volume Trends & Technical Entry and Exit Tips - baoquankhu1.vn
Vanguard (NYSE: CLB) amendment shows 0 beneficial shares after realignment - Stock Titan
Core Laboratories: Profit Margins Are Too Small To Get Excited About (NYSE:CLB) - Seeking Alpha
Middle East Tensions Impact Core Laboratories' First Quarter Forecast - Bitget
Core Laboratories Inc stock faces pressure amid oilfield services slowdown and Q4 earnings anticipat - AD HOC NEWS
Middle East Conflict Weighs On Core Laboratories' Q1 Outlook - Yahoo Finance
History Review: Is Core Laboratories Inc backed by strong institutional buying2026 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Shares Gap DownHere's Why - MarketBeat
Here’s Why Maintaining a Hold Position Is Suitable for Core Laboratories Shares at This Time - Bitget
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now - Yahoo Finance
Core Laboratories Cuts Q1 2026 Guidance Amid Mideast Turmoil - TipRanks
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE - The Malaysian Reserve
Core Laboratories cuts Q1 2026 guidance on Middle East conflict By Investing.com - Investing.com Australia
Core Lab (CLB) Revises Q1 Revenue Forecast Amid Regional Challen - GuruFocus
Core Laboratories Cuts Q1 Guidance to Account for Middle East Conflict - Moomoo
Stocks to Watch: Core Laboratories, Bark - Moomoo
Core Laboratories (CLB) Shares Drop 4.7% After Lower Q1 Guidance - gurufocus.com
Core Labs cuts Q1 guidance, citing impact of Middle East war (CLB:NYSE) - Seeking Alpha
Core Laboratories cuts Q1 2026 guidance on Middle East conflict - Investing.com
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07... - Benzinga
Core Laboratories Expects Q1 2026 Revenue An... - Benzinga
Core revises Q1 2026 guidance, now sees revenue $119M-$123M and EPS $0.05-$0.07 - tradingview.com
Core Laboratories (NYSE: CLB) trims Q1 2026 guidance amid Middle East turmoil - stocktitan.net
Core Laboratories Inc. 2025 Annual Report – Business Overview, Strategy, Operations, and Climate Initiatives - Minichart
Core Laboratories 10-K: $526.5M Revenue, $0.65 Diluted EPS - TradingView
CWA Asset Management Group LLC Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (NYSE: CLB) outlines global operations, 2025 revenue and key risk exposures - Stock Titan
Core Laboratories Revises Financials Following Tax Review () - aktiencheck.de
Core Laboratories Inc. Files Form 8-K/A SEC Report for February 2026 – Company Information and Filing Details - Minichart
Core Laboratories (NYSE: CLB) trims 2025 EPS after $4.2M tax adjustment - Stock Titan
Core Laboratories Inc. $CLB Shares Sold by Earnest Partners LLC - MarketBeat
CORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON JULY 28, 2022 - Nasdaq
ProPetro (PUMP) Jumps 9.9%: Does the Stock Have More Room to Grow? - Bitget
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Total equity of Core Laboratories Inc. – DUS:HJ1 - TradingView
Core Laboratories Inc. Earnings and Revenue – DUS:HJ1 - TradingView
Quick ratio of Core Laboratories Inc. – DUS:HJ1 - TradingView
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):